Table 2:

Subject comorbidities and AUD pharmacotherapy receipt by comorbidities

Comorbidity	Total sample			Received pharmacotherapy
	N	%		No			Yes
				N	%		N	%
All subjects	123,355	100		119,281	96.7		4,074	3.3
Comorbid medical sequelae of AUD
Acute alcohol intoxication	357	0.29		343	96.1		14	3.9
Alcohol withdrawal & related neuropsychiatric sequelae	240	0.19		227	94.6		13	5.4
Alcoholic liver disease	331	0.27		323	97.6		8	2.4
Alcoholic cardiomyopathy	9	0.010		9	100		0	0
Alcoholic gastritis	72	0.060		72	100		0	0
Alcoholic neuropathy	21	0.020		21	100		0	0
Personal history of alcoholism	22	0.020		20	90.9		2	9.1
Comorbid direct alcohol-attributable medical diseases
Chronic pancreatitis	40	0.030		40	100		0	0
Liver cirrhosis & associated sequelae	212	0.17		209	98.6		3	1.4
HIV	38	0.03		36	97.7		2	5.3
Comorbid mental health diagnoses
Schizophrenic disorders	48	0.040		45	93.7		3	6.3
Major depressive disorders	5,238	4.3		4,939	94.3		299	5.7
Bipolar affective disorders	736	0.60		685	93.1		51	6.9
Anxiety disorders	6,001	4.9		5,642	94.0		359	6.0
Mood disorders NOS	711	0.58		671	94.4		40	5.6
Psychosis NOS	268	0.22		266	99.3		2	0.75
Personality disorders	121	0.10		115	95.0		6	5.0
Post-traumatic stress disorder	543	0.44		510	93.9		33	6.1
Comorbid substance use disorders
Opioid use disorders	5,506	4.5		5,274	95.8		232	4.2
Benzodiazepine & sedative use disorders	1,306	1.1		1,238	94.8		68	5.2
Cocaine use disorders	1,757	1.4		1,717	97.7		40	2.8
Cannabis use disorders	5,940	4.8		5,867	98.8		73	1.2
Amphetamine use disorders	805	0.65		790	98.1		15	1.9
Polysubstance use disorders	507	0.41		485	95.7		22	4.3
Tobacco use disorders	4,406	3.6		4,300	97.6		106	2.4